These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19644002)

  • 1. Expectations regarding cognitive enhancement create substantial challenges.
    Racine E; Forlini C
    J Med Ethics; 2009 Aug; 35(8):469-70. PubMed ID: 19644002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognition enhancers between treating and doping the mind.
    Lanni C; Lenzken SC; Pascale A; Del Vecchio I; Racchi M; Pistoia F; Govoni S
    Pharmacol Res; 2008 Mar; 57(3):196-213. PubMed ID: 18353672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preface to cognitive enhancement.
    Kantak KM; Wettstein JG
    Handb Exp Pharmacol; 2015; 228():v. PubMed ID: 26317138
    [No Abstract]   [Full Text] [Related]  

  • 4. Cognitive enhancement: promises and perils.
    Hyman SE
    Neuron; 2011 Feb; 69(4):595-8. PubMed ID: 21338872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition-enhancing drugs.
    Mehlman MJ
    Milbank Q; 2004; 82(3):483-506, table of contents. PubMed ID: 15330974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential clinical uses of neuroactive steroids.
    Zorumski CF; Mennerick S; Isenberg KE; Covey DF
    Curr Opin Investig Drugs; 2000 Nov; 1(3):360-9. PubMed ID: 11249720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety, and ethics of cosmetic neurology far from settled.
    Flower K; Li L; Chen CY; Baggott MJ; Galloway GP; Mendelson J
    Clin Pharmacol Ther; 2010 Oct; 88(4):461-3. PubMed ID: 20856245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for delivering and evaluating the efficacy of cognitive enhancement.
    Harvey PD; Keefe RS
    Handb Exp Pharmacol; 2015; 228():5-25. PubMed ID: 25977078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing cognition in the intellectually intact.
    Whitehouse PJ; Juengst E; Mehlman M; Murray TH
    Hastings Cent Rep; 1997; 27(3):14-22. PubMed ID: 9219019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drug development for cognitive enhancement in mental health: challenges and opportunities.
    Insel T; Krystal J; Ehlers M
    Neuropharmacology; 2013 Jan; 64():2-7. PubMed ID: 23145450
    [No Abstract]   [Full Text] [Related]  

  • 11. Focusing the Neuroscience and Societal Implications of Cognitive Enhancers.
    Savulich G; Piercy T; Brühl AB; Fox C; Suckling J; Rowe JB; O'Brien JT; Sahakian BJ
    Clin Pharmacol Ther; 2017 Feb; 101(2):170-172. PubMed ID: 27557349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Part II. Cognitive domains for pharmacological intervention: implications for neuropsychiatric and neurological illnesses.
    Handb Exp Pharmacol; 2015; 228():157-9. PubMed ID: 26317140
    [No Abstract]   [Full Text] [Related]  

  • 13. Part 1. Basic approaches and perspectives.
    Handb Exp Pharmacol; 2015; 228():1-3. PubMed ID: 26317139
    [No Abstract]   [Full Text] [Related]  

  • 14. Cognitive enhancers: molecules, mechanisms and minds.
    Frenguelli BG
    Neuropharmacology; 2013 Jan; 64():1. PubMed ID: 22985720
    [No Abstract]   [Full Text] [Related]  

  • 15. Examining reports and policies on cognitive enhancement: approaches, rationale, and recommendations.
    Outram SM; Racine E
    Account Res; 2011; 18(5):323-41. PubMed ID: 21916740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experts urge smart thinking on cognitive enhancers.
    Morris K
    Lancet Neurol; 2008 Jun; 7(6):476-7. PubMed ID: 18485312
    [No Abstract]   [Full Text] [Related]  

  • 17. Closing thoughts for cognitive enhancement.
    Kantak KM; Wettstein JG
    Handb Exp Pharmacol; 2015; 228():451-9. PubMed ID: 25977093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American culture and neuro-cognitive enhancing drugs.
    Flaskerud JH
    Issues Ment Health Nurs; 2010 Jan; 31(1):62-3. PubMed ID: 19951164
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hippocampus: a target for cognition enhancers].
    Arushanian EB; Beĭer EV
    Eksp Klin Farmakol; 2007; 70(4):59-65. PubMed ID: 18078044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology.
    Cakic V
    J Med Ethics; 2009 Oct; 35(10):611-5. PubMed ID: 19793941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.